Menus Subscribe Search
injection-needle

(PHOTO: JOLOEI/SHUTTERSTOCK)

The Cheaper, Bacteria-Derived Future of Drugs

• July 19, 2013 • 6:00 AM

(PHOTO: JOLOEI/SHUTTERSTOCK)

Drugs made from plants are often too expensive for the people who need them. A group of scientists may have found a solution.

The world is in dire need of cheap drugs to combat malaria. Malaria may seem like a disease from the distant past, but world-wide, it still exacts a large toll. Even worse, today’s malaria parasites are often resistant to the standard anti-malarial drugs. Newer and more effective drugs exist, but these drugs are well out of the price range of the patients in the developing world who need them.

Part of the problem is that the newer anti-malarial drugs come from plants. For thousands of years, humans have been getting their drugs from plants. While plants make a wide range of pharmacologically active compounds, they are not very practical: they can be difficult to cultivate in large quantities, their chemical yield can be unreliable, and the product we’re interested in can be expensive to isolate from other chemicals made by the plant. Add all that up and plant-derived drugs are too expensive for the people who need them. But there may be a solution: drugs made from bacteria (and other microbes).

Different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions.

The current source of newer anti-malarial drugs is Sweet Wormwood, a plant used in traditional Chinese medicine. The Chinese have long cultivated Sweet Wormwood, but the current world acreage of this plant is much less than we need. And even if there were enough Sweet Wormwood available, extracting the active ingredient, artemisinin, is an expensive and inefficient process.

To tackle this problem, the Bill and Melinda Gates Foundation funded a California-based group of industry and academic scientists to build a microbe that can crank out suitably large amounts of artemisinin (or artemisinic acid, a closely related chemical) while fermenting in an industrial-scale vat. The group recently reported success, which they achieved by making a variety of genetic modifications to ordinary baker’s yeast. The result is a yeast that makes artemisinic acid while fermenting sugar.

In the case of artemisinin-producing yeast, the researchers modified a natural yeast metabolic system, one that converts a chemical called Acetyl-CoA into a steroid. Acetyl-CoA is made by every organism on Earth, and is a precursor of many important biological molecules. The scientists made several genetic hacks to this metabolic system, resulting in a yeast strain whose enzyme levels can be fine-tuned by adding cheap chemicals to the yeasts’ nutrient broth. With the enzyme levels set just right, the yeasts’ Acetyl-CoA-to-steroid machinery gets highjacked to make large amounts of a chemical that is just a few enzymatic steps away from artemisinic acid.

The final genetic modification was to build in new enzymes that finish the job of making artemisinic acid. To do this, the researchers took a set of enzyme genes from Sweet Wormwood and transplanted them into the genome of their engineered yeast strain. The result: a yeast that feeds on sugar and pumps out artemisinic acid, at a fraction of the cost of extracting artemisinin from hectares of Sweet Wormwood.

The project involved substantial R&D, but principles can apply broadly. One reason why this kind of Wormwood-to-yeast metabolic engineering is successful is that the Wormwood enzymes involved are not very different from yeast enzymes that have other functions, making it possible for Wormwood enzymes to function in a yeast cell. In nature, there are many variations on a basic enzyme design; different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions. There is even a strain of bacteria (which evolved naturally in a contaminated military training range) whose enzymes break down explosives for food. The chemical repertoire of the natural world is tremendous. By harnessing that repertoire in microbial factories, we can make drugs, biofuels, and other chemicals in a way that has the potential to be cheaper, safer, and less damaging to the environment.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

September 15 • 4:00 PM

The Average Prisoner Is Visited Only Twice While Incarcerated

And black prisoners receive even fewer visitors.


September 15 • 2:00 PM

Gambling With America’s Health

The public health costs of legal gambling.


September 15 • 12:23 PM

The Scent of a Conservative

We are attracted to the body odor of others with similar political beliefs, according to new research.


September 15 • 12:00 PM

2014: A Pretty Average Election

Don’t get too worked up over this year’s congressional mid-terms.


September 15 • 10:00 AM

Online Harassment of Women Isn’t Just a Gamer Problem

By blaming specific subcultures, we ignore a much larger and more troubling social pathology.


September 15 • 8:00 AM

Atheists Seen as a Threat to Moral Values

New research attempts to pinpoint why non-believers are widely disliked and distrusted.


September 15 • 6:12 AM

To Protect Against Meltdowns, Banks Must Map Financial Interconnections

A new model suggests looking beyond balance sheets, studying the network of investment as well.


September 15 • 6:00 AM

Interview With a Drug Dealer

What happens when the illicit product you’ve made your living off of finally becomes legal?


September 15 • 4:00 AM

A Feeling of Control: How America Can Finally Learn to Deal With Its Impulses

The ability to delay gratification has been held up as the one character trait to rule them all—the key to academic success, financial security, and social well-being. But willpower isn’t the answer. The new, emotional science of self-regulation.



September 15 • 2:04 AM

No Innovation Without Migration: Do Places Make People?

We know that people make places, but does it also work the other way?


September 12 • 4:00 PM

Life, Liberty, and the Pursuit of Plastic Bags

California wants you to pay for your plastic bags. (FYI: That’s not an infringement on your constitutional rights.)


September 12 • 2:00 PM

Should We Trust the Hearts of White People?

On the 50th anniversary of the Civil Rights Act, revisiting a clip of James Baldwin on the Dick Cavett Show.


September 12 • 12:00 PM

Big Government, Happy Citizens?

You may like to talk about how much happier you’d be if the government didn’t interfere with your life, but that’s not what the research shows.


September 12 • 10:00 AM

Whispering in the Town Square: Can Twitter Provide an Escape From All Its Noise?

Twitter has created its own buzzing, digital agora, but when users want to speak amongst themselves, they tend to leave for another platform. It’s a social network that helps you find people to talk to—but barely lets you do any talking.


September 12 • 9:03 AM

How Ancient DNA Is Rewriting Human History

We thought we knew how we’d been shaped by evolution. We were wrong.


September 12 • 8:02 AM

Give Yourself a Present for the Future

Psychologists discover that we underestimate the value of looking back.


September 12 • 8:00 AM

I Walked Through the Financial Crisis

Why are former Wall Street employees guiding tourists around the Financial District? Paul Hiebert signed himself up and tried to find out.


September 12 • 7:05 AM

Scams, Scams, Everywhere


September 12 • 6:17 AM

In Soccer as in Art, Motifs Matter

A new study suggests a way to quantitatively measure a team’s style through its pass flow. It may become another metric used to evaluate potential recruits.


September 12 • 4:00 AM

Comfort Food Is a Myth

New research finds that, contrary to our beliefs, such foods don’t have any special ability to improve our moods.



September 11 • 4:00 PM

Reading the Camouflage Uniforms in Ferguson: ‘You Are Now Enemy Combatants’

Why are police officers wearing green or desert camouflage in a suburban environment?


September 11 • 2:00 PM

Wage Theft: How Two States Are Fighting Against Companies That Categorize Employees as Independent Contractors

New York and Illinois have passed hard-nosed laws and taken an aggressive tack toward misclassification.


September 11 • 11:03 AM

Yes, I’m a Good Person. But Did You Hear About Her?

A new study tracks how people experience moral issues in everyday life.


Follow us


To Protect Against Meltdowns, Banks Must Map Financial Interconnections

A new model suggests looking beyond balance sheets, studying the network of investment as well.

Big Government, Happy Citizens?

You may like to talk about how much happier you'd be if the government didn't interfere with your life, but that's not what the research shows.

Give Yourself a Present for the Future

Psychologists discover that we underestimate the value of looking back.

In Soccer as in Art, Motifs Matter

A new study suggests a way to quantitatively measure a team’s style through its pass flow. It may become another metric used to evaluate potential recruits.

Searching for Everyday Morality

Experimenters use text messages to study morality beyond the lab.

The Big One

One in three drivers in Brooklyn's Park Slope—at certain times of day—is just looking for parking. The same goes for drivers in Manhattan's SoHo. September/October 2014 new-big-one-3

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.